Prognostic impact of young age on stage <scp>IV</scp> prostate cancer treated with primary androgen deprivation therapy

Abstract

Young men with metastatic prostate cancer have a poor prognosis. Young age is an independent prognostic factor in stage IV metastatic prostate cancer patients treated with primary androgen deprivation therapy.